I talked to many health CEOs out West and see big things for drug stocks

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

Amgen targets $34.3B-$35.7B in 2025 revenues with strong growth in key therapeutic areas

Amgen highlighted its robust performance in 2024, achieving 14 products annualizing over $1 billion in sales. CEO Robert ...